To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects
Clinical trial NCT05089617 · COMPLETED
Trial details
- NCT number
- NCT05089617
- Sponsor
- Youngene Therapeutics Inc., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-09
- Primary completion
- 2022-08-12
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.